Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification

Current Eye Research

Volumn 19, Issue 6, 1999, Pages 472-482

  Couderc, Bettina C ^a   De Neuville, Sylvie ^b   Douin Echinard, Victorine ^a   Serres, Brigitte ^b   Manenti, Stéphane ^b   Darbon, Jean Marie ^b   Malecaze, François ^b  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b CHU PURPAN   (France)

Author keywords

Ganciclovir; Lens epithelial cells; Proliferative capsule opacification; Retroviral vector; Suicide gene

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CELL CULTURE; CELL DESTRUCTION; CONTROLLED STUDY; DRUG SENSITIVITY; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; LENS CAPSULE; LENS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RETROVIRUS; SUICIDE GENE; VIRUS GENE;

EID: 0033387946     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.6.472.5284     Document Type: Article

References (50)

1. Wilhemus KR, Emery JM. Posterior capsule opacification following phacoemulsification. Ophthalmic Surg. 1980;11:264-267.
2. Ohadi C, Moreira H, McDonnell PJ. Posterior capsule opacification. Curr Opin Ophthalmol. 1991;2:46-52.
3. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM. Posterior capsule opacification. Surv Ophthalmol. 1992;37:73-116.
4. Hodge WG. Posterior capsule opacification after cataract surgery. Ophthalmology. 1992;105:943-944.
5. Green WR, McDonnel PJ. Opacification of the posterior capsule. Trans Ophthalmol. 1985;104:727-739.
6. Nishi O. Posterior capsule opacification. J Cataract Refract Surg. 1999;25:106-117.
7. Seward HC, Doran ML. Posterior capsulotomy and retinal detachment following extracapsular lens surgery. Br J Ophthalmol. 1994;68:379-382.
8. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Effect of primary capsulotomy with extracapsular surgery on the incidence of pseudophakic cystoid macular edema. Am J Ophthalmol. 1984;98:166-170.
9. McDonnell PJ, Krause W, Glaser BM. In vitro inhibition of lens cell proliferation and migration. Ophthalmic Surg. 1988,19:25-30.
10. Behar-Cohen FF, David T, Buechler Y, Nova MP, Houston LL, Pouliquen YM, Courtois Y. Cytotoxic effects of FGF2-Saporin on bovine lens epithelial cells in vitro. Invest Ophthalmol Vis Sci. 1995;36:2425-2433.
11. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 1986; 50:7820-7825.
12. Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma : an innovative approach for cancer therapy. Proc. Nat. Acad. Sci. USA. 1991;88:8039-8043.
13. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256:1550-1552.
14. Hurwitz MY, Marcus KT, Chevez-Barrios P, Louie K, Aguilar-Cordova E, Hurwitz RL. Suicide gene therapy for treatment of retinoblastoma in a murine model. Hum Gene Ther. 1999;10:441-448.
15. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breaefield XO, Chiocca EA. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 1994;54:5745-5751.
16. Hayashi N, Ido E, Ohtsuki Y, Ueno H. An experimental application of gene therapy for human retinoblastoma. Invest Ophthalmol Vis Sci. 1999;40:265-272.
17. Klatzmann D, Cherin P, Bensimon G, Boyer O, Coutellier A, Charlotte F, Boccaccio C, Salzmann JL, Herson S. A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Study group on gene therapy of metastatic melanoma. Hum Gene Ther. 1998;9:2585-2594.
18. Klatzmann D, Valery CA, Bensimon G, Marro B, Boyer O, Mokhtari K, Biquet B, Salzmann JL, Philippon J. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study group on gene therapy for Glioblastoma. Hum. Gene Ther. 1998;9:2595-2604.
19. Kit S. Thymidine kinase. Microbiol Sci. 1985;2:369-375.
20. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci. 1994;35:2535-2542.
21. Mashhour B, Couton D, Perricaud M, Briand P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther. 1994;2:122-126.
22. Kimura H, Sakamoto T, Cardillo JA, Spee C, Hinto DR, Gordon EM, French W, Anderson W, Ryann JS. Retrovirus-Mediated suicide gene infection in the vitreous cavity of the eye : feasibility in prevention of proliferative vitreoretinopathy. Hum Gene Ther. 1996;7:799-808.
23. Pepose JS, Leib DA. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues: recent breakthroughs in the molecular genetics of ocular diseases. Invest Ophtalmol Vis Sci. 1994;35:2662-2666.
24. Masuda I, Matsuo T, Yasuda T, Matsuo N. Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest. Ophthalmol. Vis. Sci. 1996;37:1914-1920.
25. Murata T, Kimura H, Sakamoto T, Osusky R, Spee C, Stout TJ, Hinton DR, Ryan SJ. Ocular gene therapy: experimental studies and clinical possibilities. Ophthalmic Res. 1997;29:242-251.
26. Nussenblatt RB, Csaky K. Perspectives on gene therapy in the treatment of ocular inflammation. Eye. 1997;11: 217-219.
27. Wright AF. Gene therapy for the eye. Br J Ophthalmol. 1997; 81:620-623.
28. HauswirthWW, Mclnnes RR. Retinal gene therapy 1998: summary of a workshop. Mol Vis. 1998;4:11.
29. Abraham N, Da Silva JL, Lavrousky Y, Stoltz RA, Kappas A, Dunn M, Schwartzman ML. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophtalmol Vis Sci. 1995;36:2202-2210.
30. Budenz D, Bennett J, Alonzo L, Maguire A. In vivo gene transfer into murine corneal endothelial and intrabecular meshwork cells. Invest Ophtalmol Vis Sci. 1995;36:2211-2215.
31. Seitz B, Moreira L, Baktanian E, Sanchez D, Gray B, Gordon EM, Anderson WF, Mc Donnell PJ. Retroviral vector-mediated gene transfer into keratocytes in vitro and in vivo. Am J Ophthalmol. 1998;126:630-639.
32. Jiang JX, Goodenough DA. Retroviral expression of connexins in embryonic chick lens. Invest Ophtalmol Vis Sci. 1998;39:537-543.
33. Zhang WW. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. 1999;6:113-138.
34. Reddan JR, Misra IC, Dziedzic DC. Establishment of epithelial lines from cryopreserved lenses and capsule-epithelial preparations. Invest Ophthalmol Vis Sci. 1995;36:509-513.
35. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK. High titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol. 1995; 69:7430-7436.
36. Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR 4th, Chiocca A, Breakefield XO. Retrovirus-mediated gene therapy of experimental brainneoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Cancer Gene Ther. 1996;3:99-106.
37. Maniatis T, Frisch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold-Spring Harbor Laboratory, Cold Spring Harbor Press, New York; 1982.
38. Chomczynski P, Sacchi N. Single-step method for RNA isolation by guanidium thiocyanate phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
39. Hepsen IF, Bayramalar H, Gulket A, Ozen S, Tilgen F, Evereklioglu C. Caffeic acid phenethylester to inhibit posterior capsule opacification in rabbits. J Cataract Refract Surg. 1997;23:1572-1576.
40. Hansen SO, Solomon KD, McKnight GT, Wilbrandt TH, Gwin TD, O'Morchoe DJC, Tetz MR, Apple DJ. Posterior capsule opacification and intraocular lens decentration Part I: Comparison of various posterior chamber lens designs implanted in the rabbit model. J Cataract Refract Surg. 1988;14:605-613.
41. Lungdren B, Jonsson E, Rofsen W. Secondary cataract an in vivo model for studies on secondary cataract in rabbits. Acta Ophthalmologica Suppl. 1992;205,:25-28.
42. Engel H, de la Cruz ZC, Jimenez-Abdalahin LD, Green WR, Papanicolaou RG. Cytopreparatory techniques for eye fluid specimens obtained by vitrectomy. Acta Cytol. 1982;26:551-560.
43. Odrich MG, Hall SJ, Worgul BV, Trokel SL, Rini FJ. Posterior capsule opacification : experimental analyses. Ophthalmic Res. 1985;17:75-84.
44. Wickström K, Anderson N, Johansson B, Rolfsen W, Törngen L, Von Malmborg A, Lundgren B. Rabbit and monkey lens epithelial cell (Lee) proliferation after lens extraction and 5-Fluorouracil (5-FU) administration. Invest. Ophthal Vis Sci. 1996;Suppl.2.
45. Ross G, Erickson R, Knorr D, Motulsky AG, Parkman R, Samulsi J, Strauss SE, Smith BR. Gene therapy in the United states: a five years status report. Hum Gene Ther. 1996;7:1781-1790.
46. Lieber A, Chy HY, Kirillova I, Kay V. Recombinant adenoviruses large deletions generated by cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol. 1996;70:8944-8960.
47. Goodenough DA. Lens gap junctions: a structural hypothesis for nonregulated low-resistance intercellular patways. Invest Ophthalmol Vis Sci. 1979;18:1104-1122.
48. McMasters RA, Saylors RL, Jones KE, Hendrix ME, Moyer MP, Drake RR. Lack of bystander killing in herpes simplex virus thymidine kinase-infected colon cell lines due to deficient connexin43 gap junction formation. Hum Gene Ther. 1998;9:2253-2261.
49. Tourraine RL, Vahanian N, Ramsey WJ, Blaese RM. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions. Hum Gene Ther. 1998;9:2385-2391.
50. Boucher PD, Ruch RJ, Shewach DS. Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase. Hum Gene Ther. 1998;10: 801-814.